Eurozone & Japan: Delta and cautious reopening


We dial up Eurozone GDP and inflation modestly. Japan’s growth forecast for 2021 is lowered to 2.2% from 2.8%.
Ma Tieying, Radhika Rao25 Aug 2021
  • Point 1: Reopening gains and pent-up demand are improving Eurozone’s recovery prospects
  • Point 2: Inflation is likely to remain above target in 2H, but unlikely to perturb ECB
  • Point 3: In Japan, growth recovery is delayed, due to the resurging pandemic
  • Point 4: BoJ to remain dovish; a supplementary budget around the year-end election is likely
Photo credit: AFP Photo


Eurozone

The Eurozone economy emerged from the pandemic-driven downturn in 2Q21, with GDP growth at 13.6% YoY reversing from -1.3% in 1Q. The core-4 member countries logged sequential expansion in the quarter, with trend real growth inching towards early-2020 levels (see chart). Reopening gains, pent-up demand and high vaccination rates have helped member economies recover from the trough, but bouts of Covid resurgence and supply chain disruptions might make the 2H ride bumpy.




Covid cases have risen in parts of the region, even as the count is lower than previous waves. A concurrent rise in the R0 i.e., reproduction rate underscored the prevalence of the more transmissible Delta variant. Encouragingly, the R0 rate peaked in July and has since eased. The region is progressing well on the vaccination rollout, with hospitalisation rates and usage of medical capacity still at manageable levels.

The European Commission’s economic sentiment jumped to a two-decade high in June, led by the services, industrial sector, and employment sentiments, before easing a touch in July. Retail sales are holding up, with consumption also likely to get a leg-up from forced savings in midst of restrictions. Investment interests look favourable with the investment index bouncing up into mid-21. These could get a further fillip by the upcoming outlays under the Next Generation EU initiative and upbeat housing market.

Capacity utilisation rates have risen, although industrial production in key industries is being disrupted by supply chain constraints. External trade has fared well, with the trade surplus up 12%yoy during Jan-June. Fiscal policy is likely to remain expansionary, as support measures are bound to be extended. In light of a stronger 2Q, we adjust our growth forecast modestly to 4.3% for 2021 and 4.0% in 2022.

Base effects, business resumption, supply factors and transient factors (e.g., German VAT expiry etc.) led headline inflation to quicken past the 2% target by mid-2021, with headline CPI to a multi-year high of ~2.8% in 4Q21. On the year, we adjust our inflation forecast up to 2.1% before the base effects reverse in 2022, easing the headline to 1%. The inflation development is unlikely to perturb the ECB, as the policy strategy review provides policymakers with the headroom to accept “a transitory period in which inflation is moderately above target”. This suggests that the ongoing buoyancy in inflation prints is not reason enough for the central bank to turn cautious, and that frontloading of the asset purchase program i.e., PEPP remains on course, after EUR1.25trn purchases by July.




A decision on when to end the EUR 1.85trn PEPP program (which runs till Mar22) might be undertaken in 4Q21. There is also a likelihood that even if part of the ‘crisis response’ via the PEPP ceases, bond purchases might continue under the existing regular Asset Purchase Program. The ECB is likely to lag the US Fed in its policy normalisation decisions.




Japan

GDP growth forecast for 2021 is lowered to 2.2% from 2.8%. After marginally averting a technical recession in 1H, the economy is expected to remain stagnant in 3Q and grow modestly only from 4Q onwards. This considers the longer-than-expected impact from the Covid pandemic and the possible peaking of exports cycle, which offset the positive effect of the Tokyo Olympics.

Due to the spread of Delta variant, the number of Covid cases in Japan has surged to a new record of 10-20k per day since end-July. The cumulative number of infections has exceeded 1mn, equivalent to 1% of total population. Thankfully, vaccination has also gathered pace. The share of the population that received at least one vaccine dose has risen to 50% as of late-August, while that fully vaccinated has also risen to 40%. Meanwhile, Japanese consumers appear to have adapted to the Covid state of emergency, which is evidenced by the weakening of correlation between Google mobility data and government stringency index. As such, we think consumption will stay below the normal levels for an extended period in 2H but a sharp decline could be avoided.

On the external front, exports growth may have peaked in 2Q and will likely ease towards the end of this year. Demand from the US, EU and Asia NIEs, where the vaccination rate picks up and economic activities normalise, is expected to stay resilient. On the other hand, demand from China and ASEAN (nearly 40% of Japan’s total exports) will likely weaken, as a result of China’s regulatory crackdown and the Delta-related slowdown in these economies. As far as the specific products are concerned, exports of electronics and chemicals are expected to remain strong, as the upturn in global tech investment cycle lifts demand for the Japan-made semiconductor equipment and materials. Automobile exports will likely see a slowdown, however, partly due to the continuation of global chip shortage and partly also due to the fading of low base effect.

The Bank of Japan is expected to keep the policy rates unchanged at the remaining three meetings this year (short-term: -0.1%, long-term: 0%). In contrast with the Fed that is set to withdraw QE stimulus, the BOJ still maintains a dovish stance on monetary policy due to growth uncertainties and deflation concerns. The latest move from the BOJ was to extend a special funding programme for the pandemic-hit companies by six months to March 2022. Policymakers kept the door open to extra easing, including further cutting the policy rates and targeting the longer-dated JGB yields. The divergence in monetary policy stance between the BOJ and the Fed helps to explain the yen’s 6% depreciation versus the dollar during the first seven months this year.

The government is expected to increase fiscal spending via a supplementary budget in 4Q, in face of economic uncertainties and the lower house election that will be held before the year end. Pressure on JGB yields is likely to remain mild, given that 90% of outstanding JGBs is held by the BOJ and domestic financial institutions. The 10Y JGB yield has stayed well within the BOJ’s ±0.2% target band thus far this year, slipping towards zero in August as economic uncertainties outweighed public debt concerns.

With regard to the upcoming lower house election, the ruling LDP party and its coalition are likely to win enough votes to stay in power, in the context of the fragmented oppositions. But PM Suga would face challenges to retain the position as the LDP president, given the continuous decline in the approval rating for his cabinet to record lows (Kyodo survey: 32% in mid-August). In addition to fighting the pandemic over the past one year, PM Suga has pledged to make Japan carbon neutral by 2050 (e.g., boosting the use of renewable energy, expanding green financing initiatives) and affirmed the alliance cooperation with the US (e.g., investing together in 5G, AI, semiconductor supply chains). These long-term policies, which receive the majority support within the LDP, are expected to remain basically unchanged after election.


To read the full report, click here to Download the PDF.

Ma Tieying 馬鐵英, CFA

Economist - Japan, South Korea, & Taiwan 經濟學家 - 日本, 南韓及台灣
[email protected]

Radhika Rao

Economist – India, Indonesia, Thailand & Eurozone
[email protected]


Subscribe here to receive our economics & macro strategy materials.
To unsubscribe, please click here.

The information herein is published by DBS Bank Ltd (the “Company”). It is based on information obtained from sources believed to be reliable, but the Company does not make any representation or warranty, express or implied, as to its accuracy, completeness, timeliness or correctness for any particular purpose. Opinions expressed are subject to change without notice. This research is prepared for general circulation.  Any recommendation contained herein does not have regard to the specific investment objectives, financial situation and the particular needs of any specific addressee. The information herein is published for the information of addressees only and is not to be taken in substitution for the exercise of judgement by addressees, who should obtain separate legal or financial advice. The Company, or any of its related companies or any individuals connected with the group accepts no liability for any direct, special, indirect, consequential, incidental damages or any other loss or damages of any kind arising from any use of the information herein (including any error, omission or misstatement herein, negligent or otherwise) or further communication thereof, even if the Company or any other person has been advised of the possibility thereof. The information herein is not to be construed as an offer or a solicitation of an offer to buy or sell any securities, futures, options or other financial instruments or to provide any investment advice or services. The Company and its associates, their directors, officers and/or employees may have positions or other interests in, and may effect transactions in securities mentioned herein and may also perform or seek to perform broking, investment banking and other banking or financial services for these companies. The information herein is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation. 

DBS Bank Ltd., 12 Marina Boulevard, Marina Bay Financial Centre Tower 3, Singapore 018982. Tel: 65-878-9999. Company Registration No. 196800306E. 

DBS Bank (Hong Kong) Limited, a company incorporated in Hong Kong with limited liability.  18th Floor, The Center, 99 Queen’s Road Central, Central, Hong Kong SAR.


The information set out in this website ("Information") is not directed to, or intended for distribution to or use by, any person or entity that is a citizen or resident of or located in any locality, state, country, or other jurisdiction (including but not limited to citizens or residents of the United States of America) where such distribution, publication, availability or use would be contrary to law or regulation. This Information is not an offer to sell or the solicitation of an offer to buy any security in any jurisdiction (including but not limited to the United States of America) where such an offer or solicitation would be contrary to law or regulation. This Information is published for general circulation only and does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person. Visitors accessing this website should always seek advice from an independent financial adviser regarding the suitability of the Information referred to herein (taking into account the specific investment objectives, financial situation and/or particular needs of each person in receipt of the Information) before making any investment and/or any purchase in reliance of the Information. Please refer to the actual research publications for important disclaimers and disclosures, where applicable.